August 27, 2026

Quick Answer Tinea (dermatophytosis) recurs so frequently in Indian patients for three converging reasons: the hot, humid climate creates near-ideal dermatophyte growth conditions year-round; widespread irrational use of topical steroid-antifungal combination products suppresses visible symptoms without eradicating the organism, selecting for resistant strains; and inadequate treatment duration means clinical clearance is achieved before mycological cure. Understanding these drivers — not just the presenting morphology — is what separates a GP who manages tinea effectively from one who keeps seeing the same patient back every monsoon. If you practise anywhere in India — in a city or a semi-rural setting, in a general OPD or a dedicated dermatology clinic — you have seen tinea. Almost certainly, you have seen the same patient return with it more than once. The question that should follow every relapsing tinea case is not “which antifungal should I prescribe this time” but “why did this come back.” India’s tinea burden has become a subject of specific concern in dermatology literature over the past decade, with Indian dermatologists documenting a pattern of recalcitrant, frequently recurrent dermatophytosis that appears to be more difficult to treat than the same presentations in previous decades. The reasons for this — climate, steroid misuse, treatment gaps, and emerging antifungal resistance — are discussed in this article at the level a general practitioner needs to understand to manage these cases more effectively. This is a two-part clinical discussion. Day 2 covers the full landscape of tinea in India — types, recurrence drivers, and general management principles. Day 3 goes deeper into the single most important driver of recurrence in the current Indian context: steroid-modified tinea and what it means for recognition, management, and outcome. That article is linked at the end of this one. Dermatophytes Primary causative organisms across all tinea types 3 drivers Climate + steroid misuse + inadequate treatment Trichophyton indotineae — the emerging resistant species of concern What this article covers The rising burden of fungal skin infections in India Common types — Tinea corporis, cruris, capitis and unguium Why recurrence is so common in Indian patients General principles of correct antifungal management Lifestyle and hygiene factors that worsen recurrence The hidden driver — topical steroid misuse (preview) Frequently asked questions The Rising Burden of Fungal Skin Infections in India Dermatophytosis — fungal infection of the skin, hair, and nails caused by dermatophyte fungi — is one of the most common infectious skin conditions globally. In India, it consistently ranks among the top presentations in both general practice and dermatology OPDs. The reported proportion of skin OPD attendances attributable to fungal infections in Indian studies typically ranges between 20–30%, with significant seasonal variation peaking during and immediately after the monsoon months (June–September). What has changed in recent years is not the frequency of presentation but the clinical behaviour. Indian dermatologists have documented a marked increase in presentations that are recurrent, widespread, and poorly responsive to standard antifungal regimens that previously worked reliably. Published case series and surveillance data from Indian dermatology centres have identified a specific organism — Trichophyton indotineae — as a newly characterised species that has emerged from the Indian subcontinent and shows elevated minimum inhibitory concentrations (MICs) to terbinafine, the most widely used oral antifungal for tinea in this country. The emergence of T. indotineae is not independent of clinical practice patterns — it is directly connected to the widespread misuse of topical corticosteroid-containing antifungal combination products and inadequate treatment courses, both of which have created selection pressure for resistant organisms. This is a public health-level problem with clinical-level consequences for every GP managing tinea. Common Types: Tinea Corporis, Cruris, Capitis and Unguium Tinea is named by anatomical site. The same causative organisms — primarily Trichophyton rubrum and Trichophyton mentagrophytes complex, increasingly T. indotineae in India — can infect different sites with different morphological presentations. Type Site Typical Morphology Indian Practice Notes Tinea corporis Trunk, limbs — any glabrous skin Annular or polycyclic plaques with active scaly border and central clearing Most commonly seen type; frequently steroid-modified — may lack classic ring morphology (covered in Day 3) Tinea cruris Groin, inner thighs, perineum Scaly erythematous plaques with defined advancing border; typically spares scrotal skin (unlike candidal intertrigo) More common in men; heat and occlusion major contributing factors; scrotum involvement suggests Candida or steroid-modified presentation Tinea capitis Scalp, eyebrows, eyelashes Patchy hair loss with scaling; grey-patch type (endothrix) or black-dot type; kerion (inflammatory, boggy mass) in severe cases Predominantly a paediatric presentation; oral antifungals required — topicals do not penetrate hair shaft; kerion warrants urgent management to prevent scarring alopecia Tinea unguium (onychomycosis) Nails — toenails more than fingernails Discolouration (yellow-white-brown), subungual hyperkeratosis, onycholysis, nail plate thickening and fragility Confirms fungal source — treat alongside active tinea corporis/cruris to prevent autoinoculation; longest treatment duration required of all tinea types Tinea pedis Interdigital web spaces, plantar surface Maceration, scaling, fissuring between toes; vesicular or hyperkeratotic plantar variant Often co-present with tinea unguium; common in those who wear closed shoes or walk barefoot in communal areas; a reservoir for tinea corporis/cruris autoinoculation Tinea faciei Face (non-beard) Annular or irregular erythematous patches; often atypical due to cosmetic product application and steroid use masking classic morphology Frequently misdiagnosed as eczema, rosacea, or seborrhoeic dermatitis; high index of suspicion required, especially in patients who apply fairness creams Why Recurrence Is So Common in Indian Patients Tinea recurrence is not a patient compliance problem, though compliance plays a role. It is predominantly a systems-level problem — a combination of environmental conditions, product availability, prescribing habits, and health system access that creates near-ideal conditions for dermatophytes to persist, reinfect, and develop resistance. 1. Climate and environmental load Dermatophytes are keratinophilic fungi that thrive at temperatures between 25–37°C and high ambient humidity. India’s tropical and subtropical climate provides these conditions through a significant portion of the year, and the monsoon months create conditions where sweating, skin maceration, and occlusive clothing converge. Unlike temperate climates where tinea is a seasonal problem, India provides near-continuous environmental conditions